The company said total revenues for Q1 2025 were $6.8 billion ($6.5 billion a year earlier, +3%), and that it posted a net loss of ($98) million (net income of $114 million a year earlier). The company cited the non-recurrence of gains on prior-year divestitures as the reason for the net loss.

1. 01

   The company said total revenues for Q1 2025 were $6.8 billion ($6.5 billion a year earlier, +3%), and that it posted a net loss of ($98) million (net income of $114 million a year earlier). The company cited the non-recurrence of gains on prior-year divestitures as the reason for the net loss.

2. 02

   The company said Adjusted EBITDA for Q1 2025 was $495 million ($445 million a year earlier, +11%), and that Adjusted EBITDA margin was 7.3% (6.8% a year earlier). Adjusted EBITDA is a non-GAAP measure.

3. 03

   CRH said it completed 8 acquisitions for a total consideration of $0.6 billion in Q1 2025 ($2.2 billion in Q1 of the prior year). It said year-to-date share buybacks totaled $0.5 billion and that it is starting a new $0.3 billion tranche.

4. 04

   CRH said it reaffirmed its full-year 2025 outlook, with net income of $3.7 billion to $4.1 billion, Adjusted EBITDA of $7.3 billion to $7.7 billion, and capital expenditure of $2.8 billion to $3.0 billion.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.